RE104RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

Sponsor:

Reunion Neuroscience Inc

Code:

NCT07489651

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

RE104 for Injection

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Reunion Neuroscience Inc on 2026-08-18.